![Brother of Regulator of Imprinted Sites (BORIS) suppresses apoptosis in colorectal cancer | Scientific Reports Brother of Regulator of Imprinted Sites (BORIS) suppresses apoptosis in colorectal cancer | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsrep40786/MediaObjects/41598_2017_Article_BFsrep40786_Fig1_HTML.jpg)
Brother of Regulator of Imprinted Sites (BORIS) suppresses apoptosis in colorectal cancer | Scientific Reports
![Review of Blood-Based Colorectal Cancer Screening: How Far Are Circulating Cell-Free DNA Methylation Markers From Clinical Implementation? - Clinical Colorectal Cancer Review of Blood-Based Colorectal Cancer Screening: How Far Are Circulating Cell-Free DNA Methylation Markers From Clinical Implementation? - Clinical Colorectal Cancer](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/9c26fec1-2ffb-4378-8b4d-a8b50d468d20/gr1.jpg)
Review of Blood-Based Colorectal Cancer Screening: How Far Are Circulating Cell-Free DNA Methylation Markers From Clinical Implementation? - Clinical Colorectal Cancer
![CIMB | Free Full-Text | Comprehensive Analysis of Prognostic and Genetic Signatures for General Transcription Factor III (GTF3) in Clinical Colorectal Cancer Patients Using Bioinformatics Approaches CIMB | Free Full-Text | Comprehensive Analysis of Prognostic and Genetic Signatures for General Transcription Factor III (GTF3) in Clinical Colorectal Cancer Patients Using Bioinformatics Approaches](https://www.mdpi.com/cimb/cimb-43-00002/article_deploy/html/images/cimb-43-00002-g005.png)
CIMB | Free Full-Text | Comprehensive Analysis of Prognostic and Genetic Signatures for General Transcription Factor III (GTF3) in Clinical Colorectal Cancer Patients Using Bioinformatics Approaches
![Prognostic Effect of Adenosine-related Genetic Variants in Metastatic Colorectal Cancer Treated With Bevacizumab-based Chemotherapy - Clinical Colorectal Cancer Prognostic Effect of Adenosine-related Genetic Variants in Metastatic Colorectal Cancer Treated With Bevacizumab-based Chemotherapy - Clinical Colorectal Cancer](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/359e6e0f-ba53-4198-9ad0-ec6050a779ea/gr1.jpg)
Prognostic Effect of Adenosine-related Genetic Variants in Metastatic Colorectal Cancer Treated With Bevacizumab-based Chemotherapy - Clinical Colorectal Cancer
![AGA Clinical Practice Update on Young Adult–Onset Colorectal Cancer Diagnosis and Management: Expert Review - Clinical Gastroenterology and Hepatology AGA Clinical Practice Update on Young Adult–Onset Colorectal Cancer Diagnosis and Management: Expert Review - Clinical Gastroenterology and Hepatology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/6c6a9588-8978-465d-9fb8-51d6ddb09587/gr1.jpg)
AGA Clinical Practice Update on Young Adult–Onset Colorectal Cancer Diagnosis and Management: Expert Review - Clinical Gastroenterology and Hepatology
![Clinical Practice Guideline on Screening for Colorectal Cancer in Individuals With a Family History of Nonhereditary Colorectal Cancer or Adenoma: The Canadian Association of Gastroenterology Banff Consensus - Gastroenterology Clinical Practice Guideline on Screening for Colorectal Cancer in Individuals With a Family History of Nonhereditary Colorectal Cancer or Adenoma: The Canadian Association of Gastroenterology Banff Consensus - Gastroenterology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/e259b444-e752-42df-8a90-fb0b10b1fedd/gr1.jpg)
Clinical Practice Guideline on Screening for Colorectal Cancer in Individuals With a Family History of Nonhereditary Colorectal Cancer or Adenoma: The Canadian Association of Gastroenterology Banff Consensus - Gastroenterology
![Context matters—consensus molecular subtypes of colorectal cancer as biomarkers for clinical trials - Annals of Oncology Context matters—consensus molecular subtypes of colorectal cancer as biomarkers for clinical trials - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/ebfd5979-2497-4156-96ce-18ca352a5a11/gr1.jpg)
Context matters—consensus molecular subtypes of colorectal cancer as biomarkers for clinical trials - Annals of Oncology
![Simulating the human colorectal cancer microenvironment in 3D tumor-stroma co-cultures in vitro and in vivo | Scientific Reports Simulating the human colorectal cancer microenvironment in 3D tumor-stroma co-cultures in vitro and in vivo | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-020-66785-1/MediaObjects/41598_2020_66785_Fig1_HTML.png)
Simulating the human colorectal cancer microenvironment in 3D tumor-stroma co-cultures in vitro and in vivo | Scientific Reports
![Tumour-mediated TRAIL-Receptor expression indicates effective apoptotic depletion of infiltrating CD8+ immune cells in clinical colorectal cancer - European Journal of Cancer Tumour-mediated TRAIL-Receptor expression indicates effective apoptotic depletion of infiltrating CD8+ immune cells in clinical colorectal cancer - European Journal of Cancer](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2000916616/2003178210/gr1.jpg)
Tumour-mediated TRAIL-Receptor expression indicates effective apoptotic depletion of infiltrating CD8+ immune cells in clinical colorectal cancer - European Journal of Cancer
Decoding Metastatic Colorectal Cancer to Improve Clinical Decision Making | Journal of Clinical Oncology
![Overexpression of KDM4B in clinical colorectal cancer. (A) Quantitative... | Download Scientific Diagram Overexpression of KDM4B in clinical colorectal cancer. (A) Quantitative... | Download Scientific Diagram](https://www.researchgate.net/publication/305923282/figure/fig1/AS:392167366381571@1470511394409/Overexpression-of-KDM4B-in-clinical-colorectal-cancer-A-Quantitative-real-time-PCR-of.png)
Overexpression of KDM4B in clinical colorectal cancer. (A) Quantitative... | Download Scientific Diagram
![PDF) Immunohistochemical staining for c-Kit (CD117) is a rare event in human colorectal carcinoma | Timothy Yeatman - Academia.edu PDF) Immunohistochemical staining for c-Kit (CD117) is a rare event in human colorectal carcinoma | Timothy Yeatman - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/41905014/mini_magick20190218-26219-1nty65h.png?1550516425)
PDF) Immunohistochemical staining for c-Kit (CD117) is a rare event in human colorectal carcinoma | Timothy Yeatman - Academia.edu
![Conducting Colorectal Cancer Clinical Trial? Here Is Why You Should Engage Investigators In Canada | Credevo Articles Conducting Colorectal Cancer Clinical Trial? Here Is Why You Should Engage Investigators In Canada | Credevo Articles](https://credevo.com/articles/wp-content/uploads/2017/11/colorectal_cancer_clinical_trials_feasibility_credevo.jpg)